References
- SidneySQuesenberryCPJrJaffeMGRecent trends in cardiovascular mortality in the United States and Public Health GoalsJAMA Cardiol20161559459927438477
- Guirguis-BlakeJMEvansCVSengerCAO’ConnorEAWhitlockEPAspirin for the primary prevention of cardiovascular events: a systematic evidence review for the U.S. Preventive Services Task ForceAnn Intern Med20161641280481327064410
- SkovronskyDMFeuersteinGZImaging biomarkers for diagnosis, prognosis, and treatment of Alzheimer’s diseaseWegrzynRDRudolphASFrontiers in NeuroscienceCRC PressBoca Raton, FL, USA2012103116
- MochalinVNShenderovaOHoDGogotsiYThe properties and applications of nanodiamondsNat Nanotechnol2012711123
- WangHDYangQNiuCHFunctionalization of nanodiamond particles with N,O-carboxymethyl chitosanDiam Relat Mater2010195–6441444
- VaijayanthimalaVLeeDKKimSVNanodiamond-mediated drug delivery and imaging: challenges and opportunitiesExpert Opin Drug Deliv201512573574925510332
- HoDWangCHChowEKNanodiamonds: the intersection of nanotechnology, drug development, and personalized medicineSci Adv201517e150043926601235
- HoDZarrinparAChowEKDiamonds, digital health, and drug development: optimizing combinatorial nanomedicineASC Nano2016101090879092
- XiGRobinsonEMania-FarnellBConvection-enhanced delivery of nanodiamond drug delivery platforms for intracranial tumor treatmentNanomedicine201410238139123916888
- YanMDuJGuZA novel intracellular protein delivery platform based on single-protein nanocapsulesNat Nanotechnol201051485319935648
- IgarashiRYoshinariYYokotaHReal-time background-free selective imaging of fluorescent nanodiamonds in vivoNano Lett201212115726573223066639
- HaraTBhayanaBThompsonBMolecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescenceJACC Cardiovasc Imaging20125660761522698530
- ZhangTCuiHFangCYIn vivo photoacoustic imaging of breast cancer tumor with HER2-targeted nanodiamondsProc SPIE Int Soc Opt Eng2013881588150425620857
- ManusLMMastaroneDJWatersEAGd(III)-nanodiamond conjugates for MRI contrast enhancementNano Lett201010248448920038088
- HuCMFangRHWangKCNanoparticle biointerfacing by platelet membrane cloakingNature2015526757111812126374997
- MarcinkiewiczCApplications of snake venom components to modulate integrin activities in cell-matrix interactionsInt J Biochem Cell Biol20134591974198623811033
- KnightLCRomanoJEMaurerAHIn vitro platelet binding compared with in vivo thrombus imaging using alpha(IIb)beta3-targeted radioligandsThromb Haemost19988058458519843182
- KnightLCBaidooKERomanoJEGabrielJLMaurerAHImaging pulmonary emboli and deep venous thrombi with 99mTc-bitistatin, a platelet-binding polypeptide from viper venomJ Nucl Med20004161056106410855635
- KnightLCRomanoJEBrightLTAgelanAKantorSMaurerAHPlatelet binding and biodistribution of [99mTc]rBitistatin in animal species and humansNucl Med Biol200734785586317921036
- ChangYRLeeHYChenKMass production and dynamic imaging of fluorescent nanodiamondsNature Nanotechnol20083528428818654525
- ShebuskiRJRamjitDRBencenGHPolokoffMACharacterization and platelet inhibitory activity of bitistatin, a potent arginine-glycine-aspartic acid-containing peptide from the venom of the viper Bitis arietansJ Biol Chem19892643621550215562600082
- GrabarekZGergelyJZero-length crosslinking procedure with the use of active estersAnal Biochem199018511311352344038
- SamanenJMAliFEBartonLSPotent, selective, orally active 3-Oxo-1,4-benzodiazepine GPIIb/IIIa integrin antagonistsJ Med Chem19963925486748708960544
- LiuFCraftRMMorrisSACarrollRCLotrafiban: an oral platelet glycoprotein IIb/IIIa blockerExpert Opin Investig Drugs200091126732687
- YuSJKangMWChangHCChenKMYuYCBright fluorescent nanodiamonds: no photobleaching and low cytotoxicityJ Am Chem Soc200512750176041760516351080
- LeclercJRPlatelet glycoprotein IIb/IIIa antagonists: lessons learned from clinical trials and future directionsCrit Care Med2002305S332S34012004256
- HilderbrandSAWeisslederRNear-infrared fluorescence: application to in vivo molecular imagingCurr Opin Chem Biol2010141717919879798